X4 Pharmaceuticals (XFOR) Net Margin (2018 - 2026)
X4 Pharmaceuticals' (XFOR) quarterly Net Margin came in at 183.49% in Q2 2026, up 112168.0% on a YoY basis from N/an in Q2 2025, and up 75.47% quarter-over-quarter from 747.93% in Q1 2026.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Net Margin (2018 - 2026) Analysis & Trends
X4 Pharmaceuticals (XFOR) has reported Net Margin for 5 consecutive years, with 183.49% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 112168.0% year-over-year to 183.49%; the trailing twelve-month figure through Jun 2026 stood at 568.71% (down 25762.0% YoY), and the FY2025 full-year result was 225.52%, up 124104.0% from the prior year.
- Net Margin climbed to 183.49% in Q2 2026 per XFOR's latest filing, from 747.93% in the prior quarter.
- Across five years, Net Margin topped out at 16132.68% in Q2 2024 and bottomed at 6544.82% in Q3 2024.
- Historically, Net Margin has averaged 217.26% across 3 years, with a median of 931.31% in 2025.
- The widest YoY moves for Net Margin: up 485672 bps in 2025, down 1743785 bps in 2025.
- Over 3 years, Net Margin stood at 2777.48% in 2024, then soared by 66 bps to 931.31% in 2025, then jumped by 80 bps to 183.49% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 183.49%, 747.93%, and 931.31% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 22.65% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -1.58% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 2.96% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 13.90% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 34.98% |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn | -183.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -183.49% |
| Mar 31, 2026 | -747.93% |
| Dec 31, 2025 | -931.31% |
| Sep 30, 2025 | -1,688.10% |
| Jun 30, 2025 | -1,305.17% |
| Mar 31, 2025 | 0.96% |
| Dec 31, 2024 | -2,777.48% |
| Sep 30, 2024 | -6,544.82% |
| Jun 30, 2024 | 16,132.68% |
| Mar 31, 2020 | -371.27% |
| Dec 31, 2018 | -343.94% |